Rapid reduction in the incidence of cancer of unknown primary. A population-based study

Acta Oncologica

Volumn 53, Issue 1, 2014, Pages 134-137

  Brustugun, Odd Terje ^a,b   Helland, Åslaug ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOCIAL STATUS; SURVIVAL RATE; CAUSE OF DEATH; NORWAY;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEOPLASMS, UNKNOWN PRIMARY; NORWAY; PROGNOSIS; REGISTRIES; SURVIVAL RATE; TIME FACTORS;

EID: 84890921503     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.783230     Document Type: Article

References (15)

1. Pavlidis [1] N, P entheroudakis G . C ancer of unknown primary site . Lancet 2012 ; 379 : 1428-35
2. Pavlidis N . O ptimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets . Ann Oncol 2012 ; 23(Suppl 10) : x282-5
3. Taylor MB, B romham NR, A rnold SE . C arcinoma of unknown primary: Key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines . Br J Radiol 2012 ; 85 : 661-71
4. Oien KA, D ennis JL . D iagnostic work-up of carcinoma of unknown primary: From immunohistochemistry to molecular profiling . Ann Oncol 2012 ; 23(Suppl 10) : x271-7
5. Siegel R, Naishadham D, J emal A . C ancer statistics, 2 012. CA Cancer J Clin 2012; 62 : 10-29
6. Bevier M, S undquist J, H emminki K . I ncidence of cancer of unknown primary in Sweden: Analysis by location of metastasis . Eur J Cancer Prev 2012 ; 21 : 596-601
7. Hemminki K, B evier M, H emminki A, S undquist J . S urvival in cancer of unknown primary site: Population-based analysis by site and histology . Ann Oncol 2012 ; 23 : 1854-63
8. Golfinopoulos V, P entheroudakis G, S alanti G, N earchou AD, Ioannidis JP, Pavlidis N . Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: Multiple-treatments meta-Analysis . Cancer Treat Rev 2009 ; 35 : 570-3
9. Larsen I K, S mastuen M, J ohannesen TB, L angmark F, Parkin DM, Bray F, et al . Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness . Eur J Cancer 2009 ; 45 : 1218-31
10. Hakulinen T . C ancer survival corrected for heterogeneity in patient withdrawal . Biometrics 1982 ; 38 : 933-42
11. Rand é n M, R utqvist LE, J ohansson H . C ancer patients without a known primary: Incidence and survival trends in Sweden 1960-2007 . Acta Oncol 2009 ;48: 915-20
12. Jerusalem G, R orive A, A ncion G, H ustinx R, F illet G . Diagnostic and therapeutic management of carcinoma of unknown primary: Radio-imaging investigations . Ann Oncol 2006 ; 17(Suppl 10) : x168-76 (Pubitemid 44542004)
13. Bahrami A, T ruong LD, R o JY . U ndifferentiated tumor: True identity by immunohistochemistry . Arch Pathol Lab Med 2008 ; 132 : 326-48 (Pubitemid 351328809)
14. Fizazi K, G reco F A, P avlidis N, P entheroudakis G, G roup EGW . Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup . Ann Oncol 2011 ; 22(Suppl 6) : vi64-8
15. Sagerup CM, S m ås tuen M, J ohannesen T B, H elland Å, Brustugun OT . Sex-specific trends in lung cancer incidence and survival: A population study of 40,118 cases . Thorax 2011 ; 66 : 301-7 .